Información del producto
Semaglutide is a peptide that is used as a pharmacological agent. It is an analogue of glucagon-like peptide-1 (GLP-1) and has been shown to be effective in the treatment of type 2 diabetes, obesity, and other diseases. Semaglutide inhibits the enzyme DPP-4, which is responsible for the degradation of GLP-1. As a result, semaglutide increases levels of GLP-1, which stimulates insulin release from pancreatic beta cells. This drug also helps to reduce body weight through increased satiety and reduced food intake. The efficacy of semaglutide has been demonstrated in clinical trials with patients who have autoimmune diseases such as rheumatoid arthritis or Crohn’s disease. In addition, it has been found to be safe for use in patients with hepatic impairment or diabetic neuropathy.
Propiedades químicas
Consulta técnica sobre: 3D-GLP-3875-PI Semaglutide
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
